Your browser doesn't support javascript.
loading
Innovations in Practice: A randomised controlled feasibility trial of Behavioural Activation as a treatment for young people with depression.
Kitchen, Charlotte E W; Tiffin, Paul A; Lewis, Sue; Gega, Lina; Ekers, David.
Afiliación
  • Kitchen CEW; Department of Health Sciences, University of York, York, UK.
  • Tiffin PA; Department of Health Sciences, University of York, York, UK.
  • Lewis S; Hull York Medical School, University of York, York, UK.
  • Gega L; Tees, Esk and Wear Valleys NHS Foundation Trust, Durham, UK.
  • Ekers D; School of Social and Political Science, University of Edinburgh, Edinburgh, UK.
Child Adolesc Ment Health ; 26(3): 290-295, 2021 09.
Article en En | MEDLINE | ID: mdl-32725758
ABSTRACT

BACKGROUND:

Behavioural Activation (BA) treatment effectively reduces symptoms of depression in adults and is more cost-effective than more complex therapies. Two recent systematic reviews of BA for depression in young people highlighted the need for more studies in this area.

METHODS:

In order to evaluate the acceptability of BA treatment for adolescents with depression and the feasibility of conducting a trial of this intervention in Child and Adolescent Mental Health Services (CAMHS), 22 patients from across three sites were randomised to BA or usual CAMHS care. Existing CAMHS staff were trained to deliver the manualised intervention via a brief course. Following treatment, young people and their parents/carers were asked to complete a feedback survey. Symptoms and functioning were assessed at 3- and 6-month follow-up. The trial was registered with the ISRCTN Registry (ref ISRCTN52147450; https//www.isrctn.com/).

RESULTS:

Recruitment targets were achieved through screening large numbers of CAMHS service users. Intervention adherence by the participating adolescents was high (median number of completed BA sessions was seven out of a total of eight). There were tentative suggestions of improvements following treatment; a large change in a positive direction for the BA group, but not for usual care, was observed by visual comparisons of mean scores on measures of depression, self-esteem and functioning. No adverse events were reported.

CONCLUSIONS:

The findings suggest that BA in this setting is acceptable and warrants evaluation via a fully powered randomised controlled trial.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Conductista / Depresión Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Child Adolesc Ment Health Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Terapia Conductista / Depresión Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Child / Humans Idioma: En Revista: Child Adolesc Ment Health Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido